Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;28(5):515.
doi: 10.5005/jp-journals-10071-24701.

Author Response

M Vijayakumar  1 , Velmurugan Selvam  1 , M K Renuka  1 , Ram E Rajagopalan  1
Affiliations

Author Response

M Vijayakumar et al. Indian J Crit Care Med. 2024 May.

Abstract

How to cite this article: Vijayakumar M, Selvam V, Renuka MK, Rajagopalan RE. Author Response. Indian J Crit Care Med 2024;28(5):515.

Keywords: Carbapenem-resistant enterobacterales; Ceftazidime-avibactam; Critically ill patients; Sequential organ failure assessment.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

References

    1. Salotagi S, Kannan A, Jindal A. Eternal hunt: Unravelling the challenge of CRE, the quest for perfection continues! Indian J Crit Care Med. 2024;28(5):513–514. - PMC - PubMed
    1. Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016;15:20. doi: 10.1186/s12941-016-0136-2. - DOI - PMC - PubMed
    1. Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, et al. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing enterobacterales. Clin Infect Dis. 2021;72(11):1871–1878. doi: 10.1093.cid/ciaa586. - DOI - PubMed
    1. Shaw E, Rombauts A, Tubau F, Padullés A, Càmara J, Lozano T, et al. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection. J Antimicrob Chemother. 2018;73(4):1104–1106. doi: 10.1093/jac/dkx496. - DOI - PubMed
    1. Deo SV, Deo V, Sundaram V. Survival analysis-part 2: Cox proportional hazards model. Indian J Thorac Cardiovasc Surg. 2021;37(2):229–233. doi: 10.1007/s12055-020-01108-7. - DOI - PMC - PubMed

LinkOut - more resources